MRK vs MRVL: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Marvell Technology, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Merck & Co., Inc. · Healthcare
$147.17
-4.1% upside to fair value
Med Conviction
Grade C
VS
Marvell Technology, Inc. · Technology
$258.95
-11.4% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
MRK has more upside to fair value
(-4.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
MRVL |
| Current Price |
$147.17 |
$258.95 |
| Fair Value Estimate |
$141.07 |
$229.46 |
| Upside to Fair Value |
-4.1%
|
-11.4%
|
| Market Cap |
$363.5B |
$226.8B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
29.6x
|
48.0x
|
| Price / Sales |
5.5x
|
24.0x
|
| Price / FCF |
22.6x
|
134.3x
|
| Revenue Growth YoY |
+5.1%
|
+36.5%
|
| Gross Margin |
75.4%
|
51.4%
|
| Operating Margin |
16.7%
|
16.7%
|
| Return on Equity |
6.6%
|
16.2%
|
| Dividend Yield |
2.31% |
0.09% |
| FCF Yield |
4.42%
|
0.74%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
Marvell Technology is a data infrastructure semiconductor specialist that designs custom AI accelerators, electro-optics DSPs, ethernet switching, storage controllers and interconnect silicon for hyperscale data centers, communications and carrier markets, employing roughly 7,480 people under CEO Matthew J. Murphy. Business quality is genuinely high on the demand side: revenue grew 36.5% year ove…
Accumulation Zones
| Metric |
MRK |
MRVL |
| Zone Low |
$105.80 |
$172.09 |
| Zone High |
$119.91 |
$195.04 |
| In Buy Zone? |
No
|
No
|